Herborium Group, Inc. (HBRM)
- GlobeNewswire
Herborium® Group Inc, Shareholder Update Letter (Part 2)
Proprietary AI Platform, New Partnerships and New “Natural & Clinical Hybrid” products will drive the value creation in 2023; Further improvement in Cap Table to increase Shareholders valuationHouston, Texas, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Herborium® Group, Inc. (OTC Pink: HBRM), www.Herborium.com, www.acnease.com a Botanical Therapeutics® Company and the provider of proprietary all botanical medicinal products (Botanical Therapeutics®) and interactive advanced content platform targeting derm
- GlobeNewswire
Herborium® Group Inc, Shareholder Update Letter (Part 1)
Increased Revenues and Reduced Debt (through retiring Notes) in 2022 Establish the Foundation for the Company’s Transformative Growth in 2023Houston, Texas, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Herborium® Group, Inc. (OTC Pink: HBRM), www.Herborium.com, www.acnease.com a Botanical Therapeutics® Company and the provider of proprietary all botanical medicinal products (Botanical Therapeutics®) and interactive advanced content platform targeting dermatological and other health and wellness concerns, s
- GlobeNewswire
Herborium®’ Group Half Year Update
Debt Elimination, Maintaining Sales and New Initiatives In FocusHouston, July 21, 2022 (GLOBE NEWSWIRE) -- Houston, Texas, 07/21/2022. Herborium Group, Inc. (OTC Pink: HBRM), a Botanical Therapeutics Company and provider of unique, all botanical medicinal, beauty and wellness products with a clinically validated records of efficacy and safety, announced today the following accomplishments for the first half of 2022. The Company also shares with Investors the plan for the remaining months of the
